Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Diabetovit
- Development stage
- Unknown
- Lead developer
- Emcee Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Diabetovit is an oral antioxidant nutraceutical supplement developed and marketed by Emcee Pharmaceuticals (P) Ltd., an Indian pharmaceutical company. It is formulated as a sugar-free tablet containing a combination of alpha-lipoic acid, lycopene, beta-carotene, essential vitamins (B1, B6, B12, C, E, and folic acid), and minerals (zinc, chromium, and selenium). While its name suggests a role in diabetes management, it is primarily intended as a multivitamin and antioxidant supplement to support overall health and nutritional status. It is available as a commercial product in India and is categorized as a nutraceutical rather than a prescription pharmaceutical.
- Brand names
- Diabetovit
Beyond the preview
Go deeper on Diabetovit.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Diabetovit.